Hemophagocytic lymphohistiocytosis in children: Pathogenesis and treatment

Frontiers in Pediatrics

Volumn 4, Issue MAY, 2016, Pages

  Ishii, Eiichi ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytotoxicity; Epstein Barr virus; Familial; Genetic defects; Hematopoietic stem cell transplantation; Hemophagocytic lymphohistiocytosis

Indexed keywords

EID: 85041010320     PISSN: None     EISSN: 22962360     Source Type: Journal    
DOI: 10.3389/fped.2016.00047     Document Type: Review

References (51)

1. Ishii E, Ohga S, Tanimura M, Imashuku S, Sako M, Mizutani S, et al. Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan. Med Pediatr Oncol (1998) 30:276-83. doi: 10.1002/(SICI)1096-911X(199805)30:5<276::AID-MPO3>3.0.CO;2-C
2. Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol (2007) 86:58-65. doi:10.1532/IJH97.07012
3. Ishii E, Ohga S, Imashuku S, Yamamoto K, Yasukawa M. Review of familial hemophagocytic lymphohistiocytosis (FHL) in children with focus on Japanese experiences. Crit Rev Oncol Hematol (2005) 53:209-23. doi:10.1016/j.critrevonc.2004.11.002
4. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (1999) 286:1957-9. doi:10.1126/science.286.5446.1957
5. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell (2003) 115:461-73. doi:10.1016/S0092-8674(03)00855-9
6. zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet (2005) 14:827-34. doi:10.1093/hmg/ddi076
7. zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet (2009) 85:482-92. doi:10.1016/j.ajhg.2009.09.005
8. Nagai K, Yamamoto K, Fujiwara H, An J, Ochi T, Suemori K, et al. Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes. PLoS One (2010) 5:e14173. doi:10.1371/journal.pone.0014173
9. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer (2007) 48:124-31. doi:10.1002/pbc.21039
10. Henter J, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood (1991) 78:2918-22
11. Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol (1997) 66:135-51. doi:10.1016/S0925-5710(97)00584-7
12. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol (2002) 20:323-70. doi:10.1146/annurev.immunol.20.100201.131730
13. Kagi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (1994) 265:528-30. doi:10.1126/science.7518614
14. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (1994) 370:650-2. doi:10.1038/370650a0
15. Yanai F, Ishii E, Kojima K, Hasegawa A, Azuma T, Hirose S, et al. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells. J Immunol (2003) 170:2205-12. doi:10.4049/jimmunol.170.4.2205
16. Ishii E, Ueda I, Shirakawa R, Yamamoto K, Horiuchi H, Ohga S, et al. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood (2005) 105:3442-8. doi:10.1182/blood-2004-08-3296
17. Menasche G, Feldman J, Fischer A, de Saint Basile G. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev (2005) 203:165-79. doi:10.1111/j.0105-2896.2005.00224.x
18. Chen YA, Scheller RH. SNARE-mediated membrane fusion. Nat Rev Mol Cell Biol (2001) 2:98-106. doi:10.1038/35052017
19. Hong W. Cytotoxic T lymphocyte exocytosis: bring on the SNAREs. Trends Cell Biol (2005) 15:644-50. doi:10.1016/j.tcb.2005.10.003
20. Ohadi M, Lalloz MR, Sham P, Zhao J, Dearlove AM, Shiach C, et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet (1999) 64:165-71. doi:10.1086/302187
21. Côte M, Ménager MM, Burgess A, Mahlaoui N, Picard C, Schaffner C, et al. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest (2009) 119:3765-73. doi:10.1172/JCI40732
22. Yoon HS, Kim HJ, Yoo KH, Sung KW, Koo HH, Kang HJ, et al. UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis. Haematologica (2010) 95:622-6. doi:10.3324/haematol.2009.016949
23. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood (2011) 118:4041-52. doi:10.1182/blood-2011-03-278127
24. Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol (2006) 6:940-52. doi:10.1038/nri1983
25. Stinchcombe JC, Griffiths GM. Secretory mechanisms in cell-mediated cytotoxicity. Annu Rev Cell Dev Biol (2007) 23:495-517. doi:10.1146/annurev.cellbio.23.090506.123521
26. Verhage M, Sorensen JB. Vesicle docking in regulated exocytosis. Traffic (2008) 9:1414-24. doi:10.1111/j.1600-0854.2008.00759.x
27. Sudhof TC, Rochman JF. Membrane fusion: grappling with SNARE and SM proteins. Science (2009) 323:474-7. doi:10.1126/science.1161748
28. Ueda I, Kurokawa Y, Koike K, Ito S, Sakata A, Matsumora T, et al. Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations. Am J Hematol (2007) 82:427-32. doi:10.1002/ajh.20878
29. Fukai K, Oh J, Karim MA, Moore KJ, Kandil HH, Ito H, et al. Homozygosity mapping of the gene for Chediak-Higashi syndrome to chromosome 1q42-q44 in a segment of conserved synteny that includes the mouse beige locus (bg). Am J Hum Genet (1996) 59:620-4
30. Tchernev VT, Mansfield TA, Giot L, Kumar AM, Nandabalan K, Li Y, et al. The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins. Mol Med (2002) 8:56-64
31. Jessen B, Maul-Pavicic A, Ufheil H, Vraetz T, Enders A, Lehmberg K, et al. Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chédiak-Higashi syndrome. Blood (2011) 118:4620-9. doi:10.1182/blood-2011-05-356113
32. Nagai K, Ochi F, Terui K, Maeda M, Ohga S, Kanegane H, et al. Clinical characteristics and outcomes of Chédiak-Higashi syndrome: a nationwide survey of Japan. Pediatr Blood Cancer (2013) 10:1582-6. doi:10.1002/pbc.24637
33. Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest (1993) 92:1444-50. doi:10.1172/JCI116721
34. Moss DJ, Burrows SR, Khanna R, Misko IS, Sculley TB. Immune surveillance against Epstein-Barr virus. Semin Immunol (1992) 4:97-104
35. Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol (2002) 44:283-94. doi:10.1016/S1040-8428(02)00119-1
36. Sandberg Y, van Gastel-Mol EJ, Verhaaf B, Lam KH, van Dongen JJ, Langerak AW. BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics. J Mol Diagn (2005) 7:495-503. doi:10.1016/S1525-1578(10)60580-6
37. Matsuda K, Nakazawa Y, Yanagisawa R, Honda T, Ishii E, Koike K. Detection of T-cell receptor gene rearrangement in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis. Clin Chim Acta (2011) 412:1554-8. doi:10.1016/j.cca.2011.04.036
38. Suzuki N, Morimoto A, Ohga S, Kudo K, Ishida Y, Ishii E, et al. Characteristics of hemophagocytic lymphohistiocytosis in neonates: a nationwide survey in Japan. J Pediatr (2009) 155:235-8. doi:10.1016/j.jpeds.2009.02.050
39. Whitley R. Neonatal herpes simplex virus infection. Curr Opin Infect Dis (2004) 17:243-6. doi:10.1097/00001432-200406000-00012
40. Rittichier KR, Bryan PA, Bassett KE, Taggart EW, Enriquez FR, Hillyard DR, et al. Diagnosis and outcomes of enterovirus infections in young infants. Pediatr Infect Dis J (2005) 24:546-50. doi:10.1097/01.inf.0000164810.60080.ad
41. Filipovich AH. Hemophagocytic lymphihistiocytosis (HLH) and related disorders. Hematology (2009) 2009:128-31. doi:10.1182/asheducation-2009.1.127
42. Henter JI, Samuelsson-Horne AC, Arico M, Egeler RM, Elinder G, Filipovich AH, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood (2002) 100:2367-73. doi:10.1182/blood-2002-01-0172
43. Trottestam H, Horne A, Aricò M, Egeler RM, Filipovich AH, Gadner H, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood (2011) 118:4577-84. doi:10.1182/blood-2011-06-356261
44. Kogawa K, Sato H, Asano T, Ohga S, Kudo K, Morimoto A, et al. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan histiocytosis study group. Pediatr Blood Cancer (2014) 61:1257-62. doi:10.1002/pbc.24980
45. Cooper N, Rao K, Gilmour K, Hadad L, Adams S, Cale C, et al. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood (2006) 107:1233-6. doi:10.1182/blood-2005-05-1819
46. Marsh RA, Vaughn G, Kim M-O, Li D, Jodele S, Joshi S, et al. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood (2010) 116:5824-31. doi:10.1182/blood-2010-04-282392
47. Ohga S, Kudo K, Ishii E, Honjo S, Morimoto A, Osugi Y, et al. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Pediatr Blood Cancer (2010) 54:299-306. doi:10.1002/pbc.22310
48. Nishi M, Nishimura R, Suzuki N, Sawada A, Okamura T, Fujita N, et al. Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis. Am J Hematol (2012) 87:637-9. doi:10.1002/ajh.23190
49. Balamuth NJ, Nichols KE, Paessler M, Teachey DT. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol (2007) 29:569-73. doi:10.1097/MPH.0b013e3180f61be3
50. Mahlaoui N, Ouachée-Chardin M, de Saint Basile G, Neven B, Picard C, Blanche S, et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Pediatrics (2007) 120:622-62. doi:10.1542/peds.2006-3164
51. Marsh RA, Allen CE, McClain KL, Weinstein JL, Kanter J, Skiles J, et al. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer (2013) 60:101-9. doi:10.1002/pbc.24188